AKT1 and glioblastoma: Thus, a decrease in enzymatic activity of ADAR2 in patients with multiform glioblastoma (MGB) was associated with higher Ca2+ permeability and activation of the Akt pathway, contributing to tumor growth and aggressiveness [61], [62].